The Association Between Hepatic Steatosis and Age-Related Macular Degeneration: A Cross-Sectional Study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40397903.
- Also identified by DOI 10.1097/IAE.0000000000004526.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The primary aim of this study is to estimate the association of hepatic steatosis in patients diagnosed with Age-Related Macular Degeneration (AMD). Patients with AMD and without secondary causes of chronic liver disease, alongside age- and sex-matched controls were recruited. Hepatic steatosis was determined via ultrasound imaging, and metabolic risk factors were collected using standardized surveys. A total of 98 patients were recruited (49 cases, 49 controls). Hepatic steatosis was observed in 51.0% of the AMD group compared to 30.6% in controls, a statistically significant difference (χ2(1) = 4.224, p = 0.040). In multivariable models, dyslipidemia and diabetes were the strongest predictors, with association of steatosis attenuated but still significant (OR 2.36, 95% CI 1.03-5.40, p = 0.049). This study suggests an association between AMD and the prevalence of hepatic steatosis, after controlling for metabolic risk factors.